Home / Inspections / 967937

FDA Inspection 967937 — Osiris Therapeutics Inc

Osiris Therapeutics Inc — FEI 3006638648

The FDA completed an inspection of Osiris Therapeutics Inc on April 7, 2016 in Columbia, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 7, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Columbia, MD (United States)

Facility

Other inspections at this facility

  • 1217534 (NAI Mon Aug 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1095336 (NAI Mon May 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 834769 (VAI Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736419 (NAI Thu Jul 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources